Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
3.
Neuroscience ; 167(3): 799-808, 2010 May 19.
Artículo en Inglés | MEDLINE | ID: mdl-20219645

RESUMEN

Doppel protein (Dpl) is a paralog of the cellular form of prion protein (PrP(C)). Its ectopic expression in the CNS elicits significant cerebellar Purkinje cell degeneration in some lines of PrP knockout mice. However, little is known about the Dpl-mediated neurodegenerative mechanism. To understand the molecular and intracellular pathways underlying Purkinje cell degeneration, here, we investigated the regulation of calcium-release channel protein, type 1 inositol 1,4,5-trisphosphate receptor (IP(3)R1) gene in Ngsk mice. These knockout mice express high levels of Dpl and eventually develop cerebellar degeneration. We observed that the expression level of IP(3)R1 gene is reduced in the cerebella of Ngsk mice as early as 3 months of age compared with age-matched controls along with the reduction in DNA binding activity of nuclear factor of activated-T cells (NFAT) which is transcription factor of IP(3)R1. Notably, expression of PrP restored the reduced DNA binding activity of NFATc4 by Dpl. Reduced expressions of brain-derived neurotrophic factor (BDNF) and ionotropic glutamate receptor subtype 2 or B (GluR2), which are regulated by NFATc4, were also restored by PrP expression. In light of these findings, we suggest a mechanism for Dpl-mediated Purkinje cell degeneration linked to reduced gene expression of proteins related to neuronal activity. Decrease in IP(3)R1 gene expression may lead to functional deficits and ultimately death of Purkinje cells in Ngsk mice.


Asunto(s)
Enfermedades Cerebelosas/metabolismo , Receptores de Inositol 1,4,5-Trifosfato/genética , Degeneración Nerviosa/metabolismo , Priones/metabolismo , Células de Purkinje/metabolismo , Animales , Factor Neurotrófico Derivado del Encéfalo/genética , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Enfermedades Cerebelosas/genética , Enfermedades Cerebelosas/fisiopatología , Modelos Animales de Enfermedad , Regulación hacia Abajo/genética , Proteínas Ligadas a GPI , Regulación de la Expresión Génica/genética , Ratones , Ratones Noqueados , Factores de Transcripción NFATC/genética , Factores de Transcripción NFATC/metabolismo , Degeneración Nerviosa/genética , Degeneración Nerviosa/fisiopatología , Proteínas PrPC/genética , Proteínas PrPC/metabolismo , Priones/genética , Células de Purkinje/patología , Receptores AMPA/genética , Receptores AMPA/metabolismo
4.
Protoplasma ; 234(1-4): 3-12, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18797982

RESUMEN

Fluorescent probe techniques were used to evaluate the effect of bupivacaine.HCl on the physical properties (transbilayer asymmetric lateral and rotational mobilities, annular lipid fluidity and protein distribution) of synaptosomal plasma membrane vesicles (SPMVs) isolated from bovine cerebral cortex. An experimental procedure was used based on selective quenching of both 1,3-di(1-pyrenyl)propane (Py-3-Py) and 1,6-diphenyl-1,3,5-hexatriene (DPH) by trinitrophenyl groups, and radiationless energy transfer (RET) from the tryptophans of membrane proteins to Py-3-Py. Bupivacaine.HCl increased the bulk lateral and rotational mobilities, and annular lipid fluidity in SPMVs lipid bilayers, and had a greater fluidizing effect on the inner monolayer than that of the outer monolayer. The magnitude of increasing effect on annular lipid fluidity in SPMVs lipid bilayer induced by bupivacaine.HCl was significantly far greater than magnitude of increasing effect of the drug on the lateral and rotational mobilities of bulk SPMVs lipid bilayer. It also caused membrane proteins to cluster. These effects of bupivacaine.HCl on neuronal membranes may be responsible for some, though not all, of the local anesthetic actions of bupivacaine.HCl.


Asunto(s)
Anestésicos Locales/farmacología , Bupivacaína/farmacología , Membrana Celular/efectos de los fármacos , Fluidez de la Membrana , Neuronas/efectos de los fármacos , Sinaptosomas/efectos de los fármacos , Animales , Bovinos , Membrana Celular/fisiología , Corteza Cerebral/citología , Corteza Cerebral/efectos de los fármacos , Vesículas Citoplasmáticas/efectos de los fármacos , Vesículas Citoplasmáticas/fisiología , Colorantes Fluorescentes , Neuronas/fisiología , Sinaptosomas/fisiología
5.
Dig Liver Dis ; 38(9): 668-72, 2006 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16790371

RESUMEN

BACKGROUND: Previous studies on colorectal cancer risk suggest that obesity, serum lipids and glucose might be related to colorectal carcinogenesis. This case-control study was conducted to investigate the association between obesity, serum lipids and glucose, and the risk of advanced colorectal adenoma and cancer. METHODS: Patients with histologically confirmed colorectal cancers (n=105), same number of patients with advanced colorectal adenomas matched by age and sex, and the same number of controls matched by age and sex were selected in Hanyang University Guri Hospital between January 2002 and June 2004. RESULTS: Adenoma and cancer group showed significantly higher levels of mean body mass index and serum glucose. Cancer group also showed significantly lower mean serum lipids levels than controls. We used an unordered polytomous logistic model to calculate multivariate odds ratios for advanced adenoma and cancer relative to controls. Higher serum glucose level was more strongly associated with increased risk of cancer relative to controls (odds ratio, 3.0; 95% confidence interval, 0.9-9.8) than with increased risk of advanced adenoma (odds ratio, 2.1; 95% confidence interval, 0.9-5.4). Higher body mass index was strongly associated with increased risk of advanced adenoma (odds ratio, 10.8; 95% confidence interval, 4.6-25.3), but associated with attenuated risk of cancer (odds ratio, 2.3; 95% confidence interval, 0.9-5.8). Serum triglycerides and cholesterol levels were strongly associated with reduced risk of cancer (odds ratio, 0.3; 95% confidence interval, 0.1-0.8 and odds ratio, 0.2; 95% confidence interval, 0.1-0.6, respectively). CONCLUSIONS: Obesity and hyperglycaemia are positively related to advanced colorectal adenoma formation. Furthermore, hyperglycaemia plays an important role in progression to cancer. Findings on an inverse relationship between serum triglyceride and cholesterol levels and the risk of colorectal cancer may be the secondary results from metabolic or nutritional changes in advanced colorectal cancer patients and should be clarified in further studies.


Asunto(s)
Pólipos Adenomatosos/sangre , Pólipos Adenomatosos/complicaciones , Glucemia/análisis , Neoplasias Colorrectales/sangre , Neoplasias Colorrectales/complicaciones , Lípidos/sangre , Obesidad/complicaciones , Índice de Masa Corporal , Estudios de Casos y Controles , Femenino , Humanos , Hiperglucemia/sangre , Corea (Geográfico) , Masculino , Persona de Mediana Edad , Análisis Multivariante , Factores de Riesgo
6.
Dig Liver Dis ; 38(7): 515-7, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16330268

RESUMEN

A diospyrobezoar is a type of phytobezoar that is considered to be harder than any other types of phytobezoars. Here, we describe a new treatment modality, which effectively and easily disrupted huge gastric diospyrobezoars. A 41-year-old man with a history of diabetes mellitus was admitted with lower abdominal pain and vomiting. Upper gastrointestinal endoscopy revealed three huge, round diospyrobezoars in the stomach. He was made to drink two cans of Coca-Cola every 6 h. At endoscopy the next day, the bezoars were partially dissolved and turned to be softened. We performed direct endoscopic injection of Coca-Cola into each bezoar. At repeated endoscopy the next day, the bezoars were completely dissolved.


Asunto(s)
Bezoares/patología , Bezoares/terapia , Bebidas Gaseosas , Diospyros/efectos adversos , Gastropatías/patología , Gastropatías/terapia , Administración Oral , Adulto , Bezoares/dietoterapia , Bezoares/etiología , Endoscopía , Humanos , Masculino , Gastropatías/dietoterapia
7.
J Korean Med Sci ; 14(1): 102-6, 1999 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10102534

RESUMEN

Autoimmune cholangitis is a clinical constellation of chronic cholestasis, histological changes of chronic nonsuppurative cholangitis and the presence of autoantibodies other than antimitochondrial antibody (AMA). It is uncertain whether this entity is definitely different from AMA positive primary biliary cirrhosis (PBC), though it shows some differences. We report a case of autoimmune cholangitis in a 59-year-old woman, who had been previously diagnosed as AMA-positive PBC associated with rheumatoid arthritis, has been converted to an AMA-negative and anticentromere antibody-positive PBC during follow-up. The response to ursodeoxycholic acid treatment is poor except within the first few months, but prednisolone was dropping the biochemical laboratory data.


Asunto(s)
Autoanticuerpos/inmunología , Colangitis/inmunología , Cirrosis Hepática Biliar/inmunología , Mitocondrias/inmunología , Colangitis/patología , Femenino , Humanos , Cirrosis Hepática Biliar/patología , Persona de Mediana Edad
8.
J Korean Med Sci ; 13(6): 612-6, 1998 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-9886169

RESUMEN

This study was designed to test the activity and feasibility of 5'-deoxy-5-fluorouridine (5'-DFUR) and cisplatin combination therapy in the treatment of advanced gastric cancer. Nineteen patients with inoperable and/or metastatic gastric cancer, which was histologically proven, were orally administered 5'-DFUR 1,200 mg/m2 on days 1 to 4 and days 15-18 combined with 70 mg/m2 of cisplatin being repeated every 4 weeks. Five partial responses (PRs) were achieved. Seven patients had stable disease and 6 progressed on therapy. The overall response rate was 27.7% (95% confidence interval: 9.69% to 53.5%). The median survival duration of all 18 patients was 25 weeks (9-64). The majority of patients had WHO grade I/II toxicity, but there was no treatment-related death. These data support that the combinations of oral 5'-DFUR and cisplatin are well tolerable and have a moderate activity with low toxicity in the treatment of advanced gastric cancer.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias Gástricas/tratamiento farmacológico , Administración Oral , Adulto , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Cisplatino/administración & dosificación , Esquema de Medicación , Femenino , Floxuridina/administración & dosificación , Humanos , Infusiones Intravenosas , Masculino , Persona de Mediana Edad
9.
J Korean Med Sci ; 12(5): 465-8, 1997 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-9364308

RESUMEN

A flat depressed early colon cancer (FDEC) is characterized by non-polypoid growth pattern, no association of adenomatous tissues and a tendency of even small lesions toward submucosal invasion and lymph node metastasis. It supports de novo carcinogenesis of colorectal cancer, although most colorectal cancers arise in pre-existing adenoma (adenoma-carcinoma sequence). There have been few reports of small depressed cancers because of the difficulty in colonoscopic detection and the rapid development to ulcerating advanced cancers. We report a case of flat depressed early colon cancer confined to mucosa detected by indigo carmine contrast colonoscopy.


Asunto(s)
Neoplasias del Colon/patología , Neoplasias del Colon/fisiopatología , Colonoscopía , Humanos , Masculino , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA